ACE2 and COVID-19: COVID-19 adopted a different strategy for achieving comparable affinity to SARS-2002: the interface of COVID-19 is significantly larger than that of SARS-2002 (1204 Å vs. 998 Å) with a remarkable number of interacting residues (ACE2: 30 vs. 24, Figure 1C).